Glucosamine-induced OGT activation mediates glucose production through cleaved notch1 and FoxO1, which coordinately contributed to the regulation of maintenance of self-renewal in mouse embryonic stem cells

Stem Cells and Development

Volumn 23, Issue 17, 2014, Pages 2067-2079

  Jeon, Ji Hoon ^a   Suh, Han Na ^a   Kim, Mi Ok ^a   Ryu, Jung Min ^a   Han, Ho Jae ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA ACTIN; GLUCOSAMINE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; MESSENGER RNA; NOTCH1 RECEPTOR; O GLUCOSAMINE TRANSFERASE; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 1; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR TBX5; TRANSFERASE; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; N ACETYLGLUCOSAMINYLTRANSFERASE; NOTCH1 PROTEIN, MOUSE; O-GLCNAC TRANSFERASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL CYCLE S PHASE; CELL FRACTIONATION; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; CYTOTOXICITY; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GLUCONEOGENESIS; GLUCOSE METABOLISM; LECTIN BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; GENE EXPRESSION; GENETICS; GLYCOSYLATION; METABOLISM; PHYSIOLOGY; PROTEIN DEGRADATION; PROTEIN PROCESSING;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSAMINE; GLUCOSE; GLUCOSE-6-PHOSPHATASE; GLYCOSYLATION; MICE; N-ACETYLGLUCOSAMINYLTRANSFERASES; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; REACTIVE OXYGEN SPECIES; RECEPTOR, NOTCH1;

EID: 84906562191     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0583     Document Type: Article

References (44)

1. Kang ES, D Han, J Park, TK Kwak, MA Oh, SA Lee, S Choi, ZY Park, Y Kim and JW Lee. (2008). O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic b cells. Exp Cell Res 314:2238-2248.
2. Love DC and JA Hanover. (2005). The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci STKE 2005:re13.
3. Wang S, X Huang, D Sun, X Xin, Q Pan, S Peng, Z Liang, C Luo, Y Yang, et al. (2012). Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling. PLoS One 7:e37427.
4. Hart GW, MP Housley and C Slawson. (2007). Cycling of O-linked b-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446:1017-1022.
5. Zachara NE and GW Hart. (2006). Cell signaling, the essential role of O-GlcNAc! Biochim Biophys Acta 1761:599-617.
6. Jeon JH, HN Suh, MO Kim and HJ Han. (2013). Glucosamine- induced reduction of integrin b4 and plectin complex stimulates migration and proliferation in mouse embryonic stem cells. Stem Cells Dev 22:2975-2989.
7. Soesanto YA, B Luo, D Jones, R Taylor, JS Gabrielsen, G Parker and DA McClain. (2008). Regulation of Akt signaling by O-GlcNAc in euglycemia. Am J Physiol Endocrinol Metab 295:E974-E980.
8. Kuo M, V Zilberfarb, N Gangneux, N Christeff and T Issad. (2008). O-glycosylation of FoxO1 increases its transcriptional activity towards the glucose 6-phosphatase gene. FEBS Lett 582:829-834.
9. Ramadoss P, NE Unger-Smith, FS Lam and AN Hollenberg. (2009). STAT3 targets the regulatory regions of gluconeogenic genes in vivo. Mol Endocrinol 23:827-837.
10. Conaghan J, AH Handyside, RM Winston and HJ Leese. (1993). Effects of pyruvate and glucose on the development of human preimplantation embryos in vitro. J Reprod Fertil 99:87-95.
11. Quinn P. (1995).Enhanced results inmouse and human embryo culture using a modified human tubal fluid medium lacking glucose and phosphate. J Assist Reprod Genet 12:97-105.
12. Heilig C, F Brosius, B Siu, L Concepcion, R Mortensen, K Heilig, M Zhu, R Weldon, G Wu and D Conner. (2003). Implications of glucose transporter protein type 1 (GLUT1)- haplodeficiency in embryonic stem cells for their survival in response to hypoxic stress. Am J Pathol 163:1873-1885.
13. Shafi R, SP Iyer, LG Ellies, N O'Donnell, KW Marek, D Chui, GW Hart and JD Marth. (2000). The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci U S A 97:5735-5739.
14. Haeusler RA, KH Kaestner and D Accili. (2010). FoxOs function synergistically to promote glucose production. J Biol Chem 285:35245-35248.
15. Ido-Kitamura Y, T Sasaki, M Kobayashi, HJ Kim, YS Lee, O Kikuchi, H Yokota-Hashimoto, K Iizuka, D Accili and T Kitamura. (2012). Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylation. PLoS One 7:e47231.
16. Eijkelenboom A and BM Burgering. (2013). FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol 14:83-97.
17. Housley MP, JT Rodgers, ND Udeshi, TJ Kelly, J Shabanowitz, DF Hunt, P Puigserver and GW Hart. (2008). OGlcNAc regulates FoxO activation in response to glucose. J Biol Chem 283:16283-16292.
18. Housley MP, ND Udeshi, JT Rodgers, J Shabanowitz, P Puigserver, DF Hunt and GW Hart. (2009). A PGC-1a-OGlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose. J Biol Chem 284:5148-5157.
19. Pajvani UB, CJ Shawber, VT Samuel, AL Birkenfeld, GI Shulman, J Kitajewski and D Accili. (2011). Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1- dependent manner. Nat Med 17:961-967.
20. Zhang X, S Yalcin, DF Lee, TY Yeh, SM Lee, J Su, SK Mungamuri, P Rimmele, M Kennedy, et al. (2011). FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nat Cell Biol 13:1092-1099.
21. Kitamura T, YI Kitamura, Y Funahashi, CJ Shawber, DH Castrillon, R Kollipara, RA DePinho, J Kitajewski and D Accili. (2007). A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J Clin Invest 117:2477-2485.
22. Collins QF, Y Xiong, EG Lupo, Jr., HY Liu and W Cao. (2006). p38 Mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes. J Biol Chem 281:24336-24344.
23. Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
24. Mackman N, K Brand and TS Edgington. (1991). Lipopolysaccharide- mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kB binding sites. J Exp Med 174:1517-1526.
25. Schleicher ED and C Weigert. (2000). Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int Suppl 77:S13-S18.
26. Slawson C, NE Zachara, K Vosseller, WD Cheung, MD Lane and GW Hart. (2005). Perturbations in O-linked b-Nacetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J Biol Chem 280:32944-32956.
27. Yang YR, M Song, H Lee, Y Jeon, EJ Choi, HJ Jang, HY Moon, HY Byun, EK Kim, et al. (2012). O-GlcNAcase is essential for embryonic development and maintenance of genomic stability. Aging Cell 11:439-448.
28. Jang H, TW Kim, S Yoon, SY Choi, TW Kang, SY Kim, YW Kwon, EJ Cho, and HD Youn. (2012). O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell 11:62-74.
29. Matsuura A, M Ito, Y Sakaidani, T Kondo, K Murakami, K Furukawa, D Nadano, T Matsuda, and T Okajima. (2008). O-linked N-acetylglucosamine is present on the extracellular domain of notch receptors. J Biol Chem 283:35486-35495.
30. Champattanachai V, RB Marchase, and JC Chatham. (2008). Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am J Physiol Cell Physiol 294:C1509-C1520.
31. Andrés-Bergós J, L Tardio, A Larranaga-Vera, R Gómez, G Herrero-Beaumont, and R Largo. (2012). The increase in O-linked N-acetylglucosamine protein modification stimulates chondrogenic differentiation both in vitro and in vivo. J Biol Chem 287:33615-33628.
32. Erickson JR, L Pereira, L Wang, G Han, A Ferguson, K Dao, RJ Copeland, F Despa, GW Hart, CM Ripplinger, and DM Bers. (2013). Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature 502:372-376.
33. Liu F, K Iqbal, I Grundke-Iqbal, GW Hart, and CX Gong. (2004). O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc Natl Acad Sci U S A 101:10804-10809.
34. Du XL, D Edelstein, S Dimmeler, Q Ju, C Sui and M Brownlee. (2001). Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108:1341-1348.
35. Du XL, D Edelstein, L Rossetti, IG Fantus, H Goldberg, F Ziyadeh, J Wu and M Brownlee. (2000). Hyperglycemiainduced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222-12226.
36. Jafar-Nejad H, J Leonardi and R Fernandez-Valdivia. (2010). Role of glycans and glycosyltransferases in the regulation of Notch signaling. Glycobiology 20:931-949.
37. Fortini ME. (2009). Notch signaling: the core pathway and its posttranslational regulation. Dev Cell 16:633-647.
38. Shen C, Y Chen, H Liu, K Zhang, T Zhang, A Lin and N Jing. (2008). Hydrogen peroxide promotes Ab production through JNK-dependent activation of g-secretase. J Biol Chem 283:17721-17730.
39. Kim SK, HJ Park, HS Hong, EJ Baik, MW Jung and I Mook-Jung. (2006). ERK1/2 is an endogenous negative regulator of the g-secretase activity. FASEB J 20:157-159.
40. Loh YH, Q Wu, JL Chew, VB Vega, W Zhang, X Chen, G Bourque, J George, B Leong, et al. (2006). The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38:431-440.
41. Medvedev SP, AI Shevchenko and SM Zakian. (2010). Molecular basis of Mammalian embryonic stem cell pluripotency and self-renewal. Acta Naturae 2:30-46.
42. Chew JL, YH Loh, W Zhang, X Chen, WL Tam, LS Yeap, P Li, YS Ang, B Lim, P Robson and HH Ng. (2005). Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol 25:6031-6046.
43. Okumura-Nakanishi S, M Saito, H Niwa and F Ishikawa. (2005). Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J Biol Chem 280:5307-5317.
44. Natsume A, S Kinjo, K Yuki, T Kato, M Ohno, K Motomura, K Iwami and T Wakabayashi. (2011). Gliomainitiating cells and molecular pathology: implications for therapy. Brain Tumor Pathol 28:1-12.